Please see Important Safety Information below. For a full list of indications, contraindications, warnings, precautions, and adverse events related to Acthar, please refer to the full Prescribing Information.
Acthar is indicated for use during an exacerbation or as maintenance therapy in selected cases of systemic dermatomyositis (polymyositis).
Review clinical experience with Acthar for dermatomyositis and polymyositis. Go now
The Acthar Support & Access Program (A.S.A.P.) helps with reimbursement, co-pays, and delivery. Learn more
ActharRheumatology.com is owned by Mallinckrodt. Mallinckrodt is only responsible for the content on this website.
ActharRheumatology.com is owned by Mallinckrodt.Mallinckrodt is only responsible for the content on this website.
MMF=mycophenolate mofetil. AZA=azathioprine.
CYC=cyclosporine. IVIG=intravenous immunoglobulin.
MTX=methotrexate. ILD=interstitial lung disease.
SD=standard deviation.
*Disease activity defined as elevated CPK or a decline in manual muscle testing (MMT) within 90 days prior to initiation of Acthar treatment.
1. Injecting Acthar: Introduction
2. Getting Started With Acthar
3. Preparing the Dose Ordered For You
4. Preparing to Inject
5. Drawing Up Acthar Into the Syringe
6. Choosing Where to Inject
7. Injecting Subcutaneously
8. Disposing of Used Materials
9. Storing Acthar
10. Patient Support Services
11. Important Safety Information
3. Preparing the Dose Ordered for You
7. Injecting Intramuscularly
1. La inyección de Acthar: Introducción
2. Los primeros pasos con Acthar03:15
3. Preparación de la dosis prescrita
4. Preparación para la inyección
5. Toma de Acthar con la jeringa
6. Elección del lugar dónde inyectar
7. Inyección subcutánea de Acthar
8. Cómo deshacerse de los materiales utilizados
9. Almacenamiento de Acthar
10. Servicios de apoyo a pacientes
11. Información importante para los pacientes
2. Los primeros pasos con Acthar
3. Preparación de la dosis prescrita01:23
4. Preparación para la inyección1:16
7. Inyección intramuscular de Acthar